Haloperidol-induced tardive dyskinesia in monkeys

Area of Science:

• Neuroscience
• Pharmacology
• Primate Research

Background:

• Neuroleptic drugs are widely used for psychiatric conditions.
• Long-term use can lead to serious neurological side effects.
• Understanding these complications requires suitable animal models.

Purpose of the Study:

• To investigate the chronic effects of haloperidol in cebus monkeys.
• To evaluate the cebus monkey as a model for neuroleptic-induced movement disorders.
• To characterize the development and progression of neurological signs.

Main Methods:

• Three cebus monkeys received daily oral haloperidol (0.5 mg/kg/day).
• Behavioral observations monitored for sedation, parkinsonism, dystonia, and tardive dyskinesia-like signs.
• Dose-dependency and effects of biperiden were assessed.

Main Results:

• Haloperidol induced sedation and parkinsonism within 5-7 weeks.
• Later, dose-dependent acute dystonia and seizures occurred.
• Buccolingual signs resembling tardive dyskinesia developed after 3 and 12 months.
• Biperiden differentially affected dystonia and tardive dyskinesia.

Conclusions:

• Cebus monkeys exhibit a range of neurological complications with chronic haloperidol administration.
• The observed symptoms mimic human neuroleptic-induced movement disorders.
• Cebus monkeys represent a promising animal model for studying long-term neuroleptic side effects.